DENTSPLY SIRONA INC (XRAY) Stock Price, Quote, News and Overview
NASDAQ:XRAY - Nasdaq - US24906P1093 - Common Stock - Currency: USD
XRAY Quote, Performance and Key Statistics
18.75
-0.2 (-1.06%)
The current stock price of XRAY is 18.75 USD. In the past month the price decreased by -3.55%. In the past year, price decreased by -44.71%.
XRAY Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ALC | ALCON INC | 29.9 | 45.13B | ||
| COO | COOPER COS INC/THE | 23.91 | 17.66B | ||
| ALGN | ALIGN TECHNOLOGY INC | 20.39 | 14.22B | ||
| SOLV | SOLVENTUM CORP | 17.55 | 12.61B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 30.7 | 6.01B | ||
| BLCO | BAUSCH + LOMB CORP | 25.4 | 5.55B | ||
| LNTH | LANTHEUS HOLDINGS INC | 11.27 | 5.44B | ||
| ICUI | ICU MEDICAL INC | 27.69 | 3.85B | ||
| HAE | HAEMONETICS CORP/MASS | 14.9 | 3.17B | ||
| NEOG | NEOGEN CORP | 25.1 | 2.18B | ||
| UFPT | UFP TECHNOLOGIES INC | 36.31 | 1.95B | ||
| RXST | RXSIGHT INC | N/A | 1.19B |
Related stock screener links
About XRAY
Company Profile
Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. The company is headquartered in York, Pennsylvania and currently employs 15,000 full-time employees. The company develops, manufactures, and markets a comprehensive solution offering including dental and oral health products as well as other consumable medical devices. Its Connected Technology Solutions segment includes the design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of its value-added endodontic, restorative, and preventive consumable products and small equipment used in dental offices for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and dental professional directed aligner solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for both urinary and bowel management.
Company Info
DENTSPLY SIRONA INC
Suite 60W, 221 West Philadelphia Street
York PENNSYLVANIA 28277 US
CEO: Donald M. Casey
Employees: 15000
Company Website: https://www.dentsplysirona.com/
Investor Relations: https://investor.dentsplysirona.com
Phone: 18445463722
DENTSPLY SIRONA INC / XRAY FAQ
What is the stock price of DENTSPLY SIRONA INC today?
The current stock price of XRAY is 18.75 USD. The price decreased by -1.06% in the last trading session.
What is the ticker symbol for DENTSPLY SIRONA INC stock?
The exchange symbol of DENTSPLY SIRONA INC is XRAY and it is listed on the Nasdaq exchange.
On which exchange is XRAY stock listed?
XRAY stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for DENTSPLY SIRONA INC stock?
22 analysts have analysed XRAY and the average price target is 22.8 USD. This implies a price increase of 21.62% is expected in the next year compared to the current price of 18.75. Check the DENTSPLY SIRONA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is DENTSPLY SIRONA INC worth?
DENTSPLY SIRONA INC (XRAY) has a market capitalization of 3.73B USD. This makes XRAY a Mid Cap stock.
How many employees does DENTSPLY SIRONA INC have?
DENTSPLY SIRONA INC (XRAY) currently has 15000 employees.
What are the support and resistance levels for DENTSPLY SIRONA INC (XRAY) stock?
DENTSPLY SIRONA INC (XRAY) has a support level at 18.65 and a resistance level at 19.02. Check the full technical report for a detailed analysis of XRAY support and resistance levels.
Is DENTSPLY SIRONA INC (XRAY) expected to grow?
The Revenue of DENTSPLY SIRONA INC (XRAY) is expected to decline by -2.92% in the next year. Check the estimates tab for more information on the XRAY EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy DENTSPLY SIRONA INC (XRAY) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of XRAY, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of XRAY, evaluating the profitability, health, valuation and growth aspects
- DENTSPLY SIRONA INC (XRAY) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- DENTSPLY SIRONA INC (XRAY) Sales and EPS estimates to see what analysts future expectations are.
- DENTSPLY SIRONA INC (XRAY) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- DENTSPLY SIRONA INC (XRAY) Insider and Institutional Ownership to learn about the owners and their transactions.
- DENTSPLY SIRONA INC (XRAY) Stock Chart to make your own analysis
- DENTSPLY SIRONA INC (XRAY) Latest news and press-releases to stay up to date.
Does DENTSPLY SIRONA INC (XRAY) stock pay dividends?
DENTSPLY SIRONA INC (XRAY) has a dividend yield of 3.38%. The yearly dividend amount is currently 0.55. Check the full fundamental report for a detailed analysis of XRAY dividend history, reliability and sustainability.
When does DENTSPLY SIRONA INC (XRAY) report earnings?
DENTSPLY SIRONA INC (XRAY) will report earnings on 2025-02-27, before the market open.
What is the Price/Earnings (PE) ratio of DENTSPLY SIRONA INC (XRAY)?
The PE ratio for DENTSPLY SIRONA INC (XRAY) is 10.14. This is based on the reported non-GAAP earnings per share of 1.85 and the current share price of 18.75 USD. Check the full fundamental report for a full analysis of the valuation metrics for XRAY.
What is the Short Interest ratio of DENTSPLY SIRONA INC (XRAY) stock?
The outstanding short interest for DENTSPLY SIRONA INC (XRAY) is 4.08% of its float. Check the ownership tab for more information on the XRAY short interest.
XRAY Technical Analysis
XRAY Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to XRAY. While XRAY is still in line with the averages on profitability rating, there are concerns on its financial health.
XRAY Financial Highlights
Over the last trailing twelve months XRAY reported a non-GAAP Earnings per Share(EPS) of 1.85. The EPS decreased by 0% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -6.23% | ||
| ROE | -16.58% | ||
| Debt/Equity | 0.72 |
XRAY Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 73% to XRAY. The Buy consensus is the average rating of analysts ratings from 22 analysts.
For the next year, analysts expect an EPS growth of 2.3% and a revenue growth -2.92% for XRAY